To determine the utility of magnetization transfer (MT) in the identifi cation and quantifi cation of intestinal fi brosis in a rat model of Crohn disease.
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Adler et al the Use and Care of Animals (UCUCA 08592). Thirty-eight specifi c pathogenfree adult female Lewis rats were obtained from Harlan (Indianapolis, Ind). The animals were housed under standard specifi c pathogen-free conditions and had free access to water and standard laboratory chow. During laparotomy, purifi ed peptidoglycan-polysaccharide (PG-PS) was injected intramurally (12.5-m g rhamnose per gram of body weight, 0.05 mL per injection site) into standardized locations in the cecum, distal ileum, and Peyer patches of 25 rats ( 11 ) . Thirteen control animals were similarly injected with human serum albumin (HSA). In the early phase after injection, rats injected with PG-PS develop infl ammation, with tissue edema at the injection sites in the fi rst 24 hours. The late phase, which begins approximately 14 days after laparotomy, is typifi ed by infl ammation and intense fi brosis ( 11 ) . Within 21 days after laparotomy, rats develop bowel wall thickening and intraabdominal adhesions. In addition, the bowel, liver, and spleen are studded with granulomas. Control animals injected with intestinal fi brosis. MT MR imaging depicts different molecular properties than does conventional MR imaging. Whereas the contrast between different tissues in MR is a complicated function of tissue properties and pulse sequence parameters, MT generates contrast that is primarily determined by the fraction of large macromolecules or immobilized phospholipid cell membranes in tissue ( 9, 10 ) . Because of this increased specifi city, MT should be more sensitive to the changes in collagen content that occur in fi brotic bowel tissue with strictures and, thus, enable the differentiation of those tissues from bowel tissues that contain less collagen (eg, edematous or infl amed tissues).
The purpose of this study was to determine the utility of MT in the identifi cation and quantifi cation of intestinal fi brosis in a rat model of Crohn disease. We hypothesized that MT would help differentiate fi brotic from nonfi brotic tissue and that the MT ratio would correlate with intestinal collagen content in an animal model of Crohn disease. To investigate this approach, we studied a well-characterized rat model of Crohn disease typifi ed by an early phase of intestinal infl ammation and a late phase of intestinal fi brosis.
Materials and Methods

Animal Model
All animal studies were approved by the University of Michigan Committee on T he natural history of Crohn disease involves chronic, transmural bowel wall infl ammation that often leads to luminal narrowing and results in intestinal strictures or bowel obstruction. Intestinal strictures promote the formation of fi stulas ( 1, 2 ) . Histologically, Crohn strictures typically contain a mixture of infl ammatory and mesenchymal cells along with extracellular matrix components with varying degrees of fi brosis. Clinically, strictures can behave as predominantly infl ammatory or fi brotic in nature, which creates both diagnostic and therapeutic dilemmas. An intestinal stricture that is largely infl ammatory often responds quickly to high-dose steroid therapy or therapy with potent anti-tumor necrosis factor a agents. This may relieve the intestinal obstruction but exposes the patient to the numerous potential side effects of medical therapy, including the deleterious effects of steroids on the growth and development of children (3) (4) (5) (6) (7) . An intestinal stricture that is primarily fi brotic in nature will not respond to current medical treatment; however, it requires surgical resection ( 8 ) . To our knowledge, there are currently no clinical fi ndings, laboratory measurements, or imaging modalities that allow the clinician to specifi cally determine the degree of fi brosis present in an intestinal stricture. Furthermore, efforts at investigating treatment modalities to prevent or treat intestinal fi brosis are hampered by the lack of a useful test for fi brosis to study the natural history of Crohn disease.
We investigated magnetization transfer (MT) magnetic resonance (MR) imaging to specifi cally address the need for a noninvasive test to quantitate
Implications for Patient Care
The ability to detect fi brosis in n small bowel Crohn strictures may help the clinician make decisions regarding medical therapies for nonfi brotic bowel and surgical interventions for fi brotic strictures.
The ability to identify and grade n the degree of fi brosis and monitor changes in fi brosis may assist in the evaluation of new therapeutic agents targeted at treating fi brotic strictures, which currently cannot be studied owing to the lack of a noninvasive means for monitoring changes in fi brosis.
Advances in Knowledge
We have demonstrated that magn netization transfer (MT) MR imaging depicts bowel wall fi brosis in an animal model of Crohn disease.
The MT ratio helps differentiate n fi brosis from infl ammation in vivo; the mean MT ratio ( 6 standard deviation) in the fi brotic bowel was 33.4 6 11.8, and the mean MT ratio in the infl amed bowel was 15.7 6 2.1 ( P = .02). 
Evaluation of Gross Pathologic Specimens
After the fi nal image was obtained, rats were sacrifi ced and the cecums were grossly evaluated by an observer blinded to the treatments. Evaluation was performed primarily by E.M.Z., P.S.R., and J.A., who have 20, 7, and 4 years of experience, respectively, with this method of assessment. Cecal wall thickening, mesenteric thickening, and adhesions were graded on a scale of 0 to 4 according to the degree of opacity of the bowel wall and the perceived thickness at palpation. The composite gross gut score, a well-established means of assessment of fi brosis, was calculated as the sum of the individual scores and determined for all rats upon dissection. (15) (16) (17) .
Histologic Evaluation
Samples of the excised cecum were fi xed in neutral buffered formalin, embedded laparotomy and injection of PG-PS or HSA, as described earlier. MT MR imaging was performed in a standard imaging mode at 10 kHz to generate images with optimal MT ( M sat images) and at 100 kHz off-resonance to generate images without MT ( M 0 images). The MT ratio in the cecal wall was calculated as follows: 100(1 2 MT on M sat image/MT on M 0 image). Representative conventional and MT images in normal rats are shown in Figure 2 .
Four in vivo experiments were performed ( Table 1 ). The fi rst two experiments (experiments 1 and 2) were designed to determine whether MT could help differentiate fi brotic from nonfibrotic bowel in vivo. These rats underwent their fi nal MT imaging examination 21 days after laparotomy. In the next experiment (experiment 3), we evaluated whether MT imaging could help assess changes in fi brosis over time. Rats underwent MR imaging on a weekly basis for 28 days after laparotomy. The fourth experiment (experiment 4) specifi cally addressed the question of whether MT MR imaging could help differentiate fibrosis from infl ammation. Rats evaluated in the early phase underwent their fi nal MT MR imaging examination 1 day after laparotomy, during the time of intense infl ammation and minimal fi brosis. Rats evaluated in the late phase underwent weekly MT imaging examinations until their fi nal examination, performed 21 days after laparotomy, during the HSA do not develop late-phase infl ammation or fi brosis ( Fig 1 ) .
Imaging Protocol
All MR images were obtained with a 2.0-T, 31-cm clear-bore system equipped with actively shielded gradients (Inova; Unity Varian, Palo Alto, Calif). Resected intestinal tissue from two ratsone control rat and one rat injected with PG-PS with late-phase fibrotic enterocolitis-was imaged ex vivo in nonimaging nuclear MR spectroscopy mode. MT z-spectra were obtained with 25 off-resonance frequencies (logarithmically from 100 Hz to 100 kHz) and four radiofrequency (RF) power levels (2.82, 5.64, 11.28, and 22.55 m T) ( 12 ) . The results of these studies were used to select the off-resonance frequency and RF power to generate signifi cant MT and minimize direct RF saturation ( 13 ) .
For in vivo imaging, a multisection gradient-echo pulse sequence (repetition time msec/echo time msec = 400/3.5) was used to generate MT with a 20-msec sinc pulse applied 10 kHz off-resonance. The 20-msec MT pulse had an effective continuous wave RF power of 312 Hz (7.33 m T) ( 14 ) . Other imaging parameters were as follows: 2-mm-thick sections, 0.47-mm in-plane resolution, and 30° excitation pulse. For in vivo studies, a few rats from each experiment were sedated with isofl urane and underwent baseline MT MR imaging 1 day before 
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Adler et al in paraffi n, and sliced. Specimens were removed from paraffi n and stained with Masson trichrome. With use of an eyepiece reticle in a standard light microscope, the thickness of the cecal wall was measured by an observer (P.S.R.) blinded to the treatment group. Measurements were made in two to six regions in which full-thickness tissue was clearly identifi able, not associated with plicae, and judged to be suitably oriented. The mean thickness was calculated across all measurements. Two gastrointestinal pathologists (B.J.M. and C.P.G.) blinded to the treatment history graded the tissue in consensus with regard to the degree of infl ammation and degree of fi brosis on a scale of 0 to 4 ( Table 2 ) ( 18 ) . The thickness of the resected cecal tissue was measured at microscopy in the 21 rats evaluated in experiments 1-3 (16 injected with PG-PS and fi ve control animals, Table 1 ). The histologic fi brosis
Figure 2
Figure 2: Coronal MR images of normal rat abdomen obtained with a spin-echo sequence (3000/20) and RF saturation pulses at (a) 100 kHz and (b) 10 kHz off-resonance. The gaussian-shaped MT saturation pulses were applied with a duration of 120 msec during the quiescent periods of the multisection imaging sequence. The RF pulse at 100 kHz off-resonance is outside of the resonance line of the immobilized molecules and does not generate any MT, whereas the RF pulse at 10 kHz generates substantial MT. (c) Image of the computed MT ratio. Normal bowel has a low MT effect, whereas a stiff tissue such as muscle has a high MT effect owing to the high content of myosin and other muscle macromolecules. # = cecum, * = muscle of the lower extremity.
score was determined in the 17 rats evaluated in experiment 4 (nine injected with PG-PS and eight control animals). When all rats evaluated in the late phase were taken together, the MT ratio of the 18 rats injected with PG-PS (mean MT ratio, 24.7 6 1.9) was signifi cantly higher than that of the nine rats injected with HSA (mean MT ratio, 10.8 6 1.7) ( P = .0001, Fig 3 ) . Rats injected with PG-PS developed thick fibrotic bowel, which was seen histologically as bands of collagen through the submucosa ( Fig 4b ) and hyperplasia of the muscularis externa. The intestines of control animals essentially appeared normal, without fi brosis ( Fig 4d ) . The MT MR images of the rats in jected with PG-PS that developed fi brotic bowel demonstrated thickened bowel wall with intense red signals, which represents a higher MT ratio on color gradient images ( Fig 4a ) ; this fi nding was not seen in control rats without fi brosis ( Fig 4c ) .
Collagen Measurement
Bonferroni adjustment for multiple comparisons as appropriate. For all ordinal comparisons (histologic fi brosis score, histologic infl ammation score, and gross gut score), the Spearman correlation was performed with Bonferroni adjustment for multiple comparisons as appropriate. The diagnostic accuracy of the MT ratio for fi brosis was assessed with receiver operating characteristic curves. All statistical analyses were performed with software (Stata 10.1 for Mac; StataCorp, College Station, Tex). , rats injected with PG-PS developed intense fi brosis whereas rats injected with HSA did not (mean histologic fi brosis score: 4.0 6 0.0 vs 1.0 6 0.4, respectively; P = .0003). The mean histologic fi brosis score in rats injected with PG-PS increased signifi cantly from day 1 to day 21 (from 0.2 6 0.2 to 4.0 6 0.0, P , .0001) ( Fig 7 , center chart) . This paralleled an increase in the mean MT ratio of rats injected with PG-PS from day 1 to day 21 (from 15.7 6 2.1 to 33.4 6 5.0, P = .02) ( Fig 7 , right chart) . The MT ratio in rats injected with HSA did not change signifi cantly between day 1 and day 21 ( P = .69). Conversely, the infl ammation score decreased during this period ( Fig 7 , left chart) . The increase in the MT ratio concomitant with the increase in tissue fi brosis and decrease in tissue infl ammation supports our hypothesis that it is sensitive to changes in fi brosis but not to changes in tissue infl ammation.
Results
MT Ratio in Fibrotic versus
Trichrome Colorimetric Analysis
To establish that the two methods of collagen measurement were in agreement, we correlated fi ndings with the two methods: MatLab trichrome colorimetric analysis and Western blot for type I collagen. Standardized collagen area determined with MatLab trichrome colorimetric analysis showed correlation with tissue collagen determined with Western blot analysis for type I collagen (20 rats, R = 0.69, P = .0007) (Fig E5,  online) .
Discussion
In this study, we demonstrated that MT can help identify intestinal fi brosis in vivo in a rat model of Crohn disease. We found that the MT ratio in fi brotic segments of bowel wall in rats with PG-PS-induced intestinal fi brosis was higher than that in the nonfi brotic bowel of control animals treated with HSA. Biomarkers and imaging modalities are extremely useful in clinical practice and in clinical trials for assessing clinical activity from Crohn disease that refl ects tissue infl ammation. Currently, no available tool exists that assesses tissue value of the MT ratio in the prediction of fi brosis assessed with the histologic fi brosis score was 44% (four of nine rats) and the negative predictive value was 86% (six of seven rats). In the prediction of fi brosis with the MT ratio, the area under the receiver operating characteristic curve was 0.88 with use of collagen measured with Western blot analysis and 0.67 with histologic fi brosis score (Fig E4, online) .
MT Ratio Parallels the Development of Fibrosis
Rats were studied with serial MT imaging to determine the sensitivity of MT to changes in fi brosis over time. Two cohorts were studied (experiment 3 and the late phase of experiment 4; see Table 1 and Table E3 [online]). The MT ratio increased in rats injected with PG-PS, which is consistent with the onset of the late fibrotic phase of PG-PSinduced enterocolitis ( 15 ) . Rats injected with HSA demonstrated no signifi cant change in MT ratio over time. The time course of all rats is shown in Figure 6 . Experiment 4 ( Table 1 ) addressed the ability of MT MR imaging to help differentiate infl ammation from fi brosis. None of the rats demonstrated fi brosis 1 day after laparotomy (early phase) (mean histologic fi brosis score: 0.2 6 0.2 in rats injected with PG-PS and 0.8 6 0.3 in control rats; P = .13). Within
MT Ratio in Fibrotic vs Infl amed Bowel
The MT ratio showed good correlation with the quantity of type I collagen (19 rats; R = 0.74, P = .0003; Fig 5 ) . In addition, compared with control animals, rats injected with PG-PS expressed markedly increased type I collagen, as measured with Western blot analysis (19 rats; 319.4 densitometric units [DU] 6 22.4 vs 1404.6 DU 6 179.9, respectively; P = .003; Fig E1,  online) . The MT ratio was also shown to correlate with the gross fi brosis score (35 rats; r = 0.61, P = .0001; Fig E2a,  online) and with tissue thickness at histologic examination (19 rats; R = 0.55, P = .015; Fig E2b, online) . Tissue infl ammation showed a weak correlation with MT ratio (16 rats; r = 0.49, P = .057; Fig E3, online) .
To determine the ability of MT to help differentiate between fi brotic and nonfi brotic tissues, arbitrary cutoff values were assigned for collagen ( Ն 500 DU at Western blot analysis, 19 rats), fi brosis (histologic fi brosis score Ն 2, 16 rats), and MT ratio (MT ratio Ն 15, 16 rats). Cutoff values were assigned on the basis of visual assessment of the data, with determination of these numbers as the natural break points (Tables E1 and E2, online) . Given these parameters, the positive predictive value for MT ratio in the prediction of fi brosis measured with collagen Western blot analysis was 92% (12 of 13 rats) and the negative predictive value was 83% (fi ve of six rats). The positive predictive 
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Adler et al ( 14 ) . Other imaging parameters were as follows: 2-mm-thick sections, 469-m m in-plane resolution, and 30° excitation pulse. MT images are colorized with color gradients representing the MT ratio (scale is shown in Fig 2) . Note that the MT ratio in the bowel of the rat injected with PG-PS is high, which is indicated by the red color (arrows in a ); this area corresponds to the thickened bowel wall of the same rat (b) with markedly expanded collagen (arrows in b ), which is stained blue. The MT ratio in the bowel of the rat injected with HSA is low (arrows in c ). This area corresponds to the thin bowel wall of the same rat (d) with a normal thin layer of collagen (arrows in d ), which is stained blue. # = cecum, * = paraspinous muscle.
patterns differed between fi brotic and infl ammatory strictures in ileal Crohn disease. Nylund et al ( 25 ) made similar observations. They found that the stratifi cation of tissue layers at US is more discrete in fi brotic strictures than in tissue layers of infl ammatory strictures. Although this is more specific than previous imaging studies, conventional US does not appear to be able to help surgery. They found that PET/CT was sensitive to infl ammation but unable to depict differences among fi brosis, muscular hypertrophy, and infl ammation ( 23 ) . Ultrasonography (US) is exquisitely sensitive to bowel wall changes in accessible regions of bowel, although its ability to help differentiate infl ammation from fi brosis has traditionally been limited. Maconi et al ( 24 ) found that echo fi brosis. Because fi brosis is key to the natural history of Crohn disease, it follows that there is no test that is able to adequately monitor the natural history of Crohn disease. To our knowledge, MT MR imaging is the first noninvasive cross-sectional imaging technique that can semiquantitatively depict intestinal fi brosis. Other imaging modalities have been investigated in an attempt to identify a technique for the noninvasive quantifi cation of bowel wall fi brosis. Findings at computed tomography (CT) thought to be suggestive of fi brosis include bowel wall thickening in the absence of contrast enhancement ( 21 ) . However, this has not been demonstrated in studies directly assessing resected intestinal tissue ( 22 ) . Positron emission tomography (PET)/CT was initially thought to have great potential in the quantitation of intestinal fi brosis. However, the high concentration of leukocytes in all strictures, both fi brotic and nonfi brotic, leads to a substantial accumulation of fl uorine 18 fl uorodeoxyglucose, which overshadows any ability to detect collagen in strictures. This was illustrated by Jacene et al ( 23 ) , who investigated PET/CT in patients known to have small bowel strictures before Imaging with MT has the potential to be readily available for implementation in clinical practice. It uses a pulse sequence available on many MR imaging units currently in use in clinical practice. Implementation of this sequence does not require hardware upgrades but is a matter of software programming. We are currently conducting in vivo human MT imaging to study this technique, determine its resolution, and demonstrate its reliability and accuracy in patients with Crohn disease. If MT is found to be similarly sensitive to fi brosis in the human bowel wall, it may directly benefi t patient care. Having the ability to quantify intestinal fi brosis should aid the clinician in determining if a patient with obstructive symptoms has a fi brotic stricture requiring surgery or dilation or if he or she has an infl ammatory stricture that is more likely to respond to escalation of medical management.
Our study had the following limitations. First, the PG-PS model develops fi brosis in a segmental fashion, spreading out from the region of injection. Because the cecum in rats is large and mobile, the exact position of the cecum injected cannot be identifi ed on imaging studies. This is a disadvantage as we may not be creasing bowel wall fi brosis beginning at approximately 1-2 weeks after injection.
In these experiments, we demonstrated that the MT ratio is sensitive to these changes in bowel fi brosis that were detected in the rats treated with PG-PS but not in control animals that did not develop fi brosis. Detecting changes in fi brosis over time has clinical utility for monitoring patients with a stricturing phenotype of Crohn disease. This fi nding also has the potential to be of great benefi t as a research tool for monitoring the natural history of Crohn disease.
We further demonstrated the ability of MT to help differentiate fi brotic from infl amed bowel in the PG-PS model. We took advantage of an interesting characteristic of this model where there is an early phase of infl amed bowel and a late phase that is dominated by tissue fi brosis. By studying the MT in both phases, we demonstrated that MT is clearly sensitive to changes in fi brosis but is relatively insensitive to infl ammation. As in the human disease, infl ammation and fi brosis are closely linked and do not exist independently in the chronic phase of PG-PS-induced enterocolitis. Therefore, defi nitive proof of this concept will await histologic studies in humans. Our fi ndings support our hypothesis and differentiate subtle gradations in fi brosis. US elasticity imaging was recently shown to enable the quantitative measurement of bowel wall fi brosis in a rat model of Crohn disease ( 26 ) . This technique seems to hold great promise. MR enterography provides detailed images of the bowel and extraintestinal structures and clinically useful information ( 27 ) . Punwani et al ( 28 ) found that layered enhancement at MR enterography is associated with fi brostenotic disease. However, they also found that homogeneous enhancement had a stronger association with fi brostenotic disease. Previous studies have attempted to differentiate fi brotic from nonfi brotic signal on the basis of their signal intensities at T1-versus T2-weighted imaging or their specifi c pattern of enhancement with T2-weighted fast imaging employing steady-state acquisition sequences ( 29 ) . To our knowledge, however, no study to date has clearly demonstrated the ability to differentiate fi brotic from nonfi brotic bowel ( 30 ) .
We also demonstrated that MT imaging can depict changes in the degree of tissue fi brosis over time. Rats with PG-PS-induced enterocolitis develop a typical sequence of events with early inflammation that progresses to in-
Figure 6
Figure 6: Bar chart shows the changes in the MT ratio over time. MT MR imaging was performed before laparotomy ( Pre-op ) and then weekly thereafter for up to 28 days. Note the progressive increase in the MT ratio in rats injected with PG-PS. This is consistent with the development of intestinal fi brosis in this model. Control animals had a lower MT ratio and did not develop fi brosis. There were no signifi cant differences between the MT ratio in rats injected with PG-PS and that in control rats before ( P = .4) and 7 days after ( P = .2) laparotomy. Beginning 2 weeks after injection, the MT ratio in rats injected with PG-PS was signifi cantly greater than that in control rats ( P = .003). Numbers are numbers of rats.
Figure 7
Figure 7: Bar charts show the changes in histologic infl ammation, histologic fi brosis, and MT ratio from 1 day (early infl ammatory phase) to 21 days (late fi brotic phase) after laparotomy. Note that the MT ratio of rats injected with PG-PS increased from day 1 to day 21, in parallel with the increase in fi brosis and opposite to the change in infl ammation, which decreased somewhat. Control animals demonstrated no increase in MT ratio or fi brosis, and infl ammation resolved completely.
measuring the ROI in the region of maximal fi brosis. However, this does improve our ability to be blinded to the treatment group when assessing the MR images. In addition, measuring the cecum circumferentially and averaging the ROIs across fi brotic and nonfi brotic regions would result in a lower mean MT ratio due to regression to the mean. Therefore, if the results of this study are affected by this, then our data would under-represent the strength of the association between MT ratio and fi brosis. The other limitation to this study, as in other studies of MR imaging of the intestines, is bowel motility. We performed MR imaging in sedated rats without the use of antimotility agents. Normal peristaltic motion creates substantial movement artifact, which interferes with image quality. In clinical practice, patients are frequently given an antimotility agent such as glucagon to decrease motion artifact. In this study, no antimotility agents were given. We did, however, exclude images that were of suffi ciently poor quality to be uninterpretable. In imaging of other organs such as heart and lung, images can be gated for rhythmic movement. Future advances in programming may enable us to account for more complex motion such as peristalsis, making imaging of the bowel more practical.
In summary, we have demonstrated that MT can help detect fi brosis and that the MT ratio correlates with tissue collagen levels and is sensitive to changes in fi brosis over time.
Practical applications: A noninvasive method for determining the fi brotic content of small bowel strictures in Crohn disease could be used to inform treatment decisions. Prospective human studies will need to be performed to determine how this method alters patient outcomes. MT may also provide a tool to monitor changes in fi brosis over time and may lend insight into the natural history of Crohn disease. MT may also be useful to study the effect of current and nascent therapies on altering intestinal fi brosis.
